Clinical Trials Browser

Not yet recruiting × OTHER_GOV × Breast Neoplasms × Clear all

NCT07464769 2026-03-11

KompXX

Phase NA Not yet recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07425379 2026-02-24

Prehabilitation in Breast Cancer Surgery

Phase NA Not yet recruiting

Breast Neoplasms

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07371702 2026-01-29

PERMS

Not yet recruiting

Breast Neoplasms

NCT07273357 2025-12-09

FUTURE

Not yet recruiting

Breast Neoplasms

NCT07243418 2025-11-21

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07146009 2025-08-28

Targeted Nerve Surgery for the Prevention of Post-Mastectomy Pain Syndrome: A Randomized Trial

Phase NA Not yet recruiting

Breast Neoplasms

NCT07136974 2025-08-22

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07101159 2025-08-03

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

Phase 2 Not yet recruiting

Breast Neoplasms

NCT06751407 2025-07-03

Single-level and Two-level Serratus Posterior Superior Intercostal Plan Block (SPSIPB)

Phase NA Not yet recruiting

Breast Neoplasms, Pain

NCT07047755 2025-07-02

Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Phase 2 Not yet recruiting

Breast Neoplasms

NCT06990165 2025-05-25

Photobiomodulation in Radiodermatitis in People With Breast Cancer

Phase NA Not yet recruiting

Breast Neoplasms, Radiodermatitis

NCT06934733 2025-04-18

The Efficacy of Oral Cryotherapy in Preventing TROP2-ADC-Induced Oral Mucositis in Patients With Advanced Breast Cancer

Phase NA Not yet recruiting

Breast Neoplasms

NCT06788197 2025-03-26

A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT06663748 2024-10-29

ARX788 in HER2-positive Metastatic Breast Cancer Patients

Phase 2 Not yet recruiting

Breast Neoplasms